Person who experienced the adverse event (patient)
| Event ID | CASEID | CASEVERSION | I F COD | EVENT DT | MFR DT | INIT FDA DT | FDA DT | REPT COD | AUTH NUM | MFR NUM | MFR SNDR | LIT REF | AGE | AGE COD | AGE GRP | GNDR COD | E SUB | WT | WT COD | REPT DT | TO MFR | OCCP COD | REPORTER COUNTRY | OCCR COUNTRY |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 100160733 | 10016073 | 3 | F | 20050928 | 20140620 | 20140317 | 20140630 | EXP | US-PFIZER INC-2014073012 | PFIZER | 72.00 | YR | F | Y | 72.56000 | KG | 20140630 | N | LW | US | US |
Drug(s) used by person
| Event ID | CASEID | DRUG SEQ | ROLE COD | DRUGNAME | PROD AI | VAL VBM | ROUTE | DOSE VBM | CUM DOSE CHR | CUM DOSE UNIT | DECHAL | RECHAL | LOT NUM | EXP DT | NDA NUM | DOSE AMT | DOSE UNIT | DOSE FORM | DOSE FREQ |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 100160733 | 10016073 | 1 | PS | Lipitor | 1 | ORAL | 10 MG, DAILY | D | 20702 | 10 | MG | FILM-COATED TABLET | |||||||
| 100160733 | 10016073 | 2 | SS | Lipitor | 1 | ORAL | 20 MG, DAILY | D | 20702 | 20 | MG | FILM-COATED TABLET | |||||||
| 100160733 | 10016073 | 3 | SS | ATORVASTATIN CALCIUM | 1 | ORAL | 20 MG, DAILY | D | 20702 | 20 | MG | FILM-COATED TABLET | |||||||
| 100160733 | 10016073 | 4 | C | DYAZIDE | 1 | 1 DF, DAILY | D | 0 | 1 | DF | |||||||||
| 100160733 | 10016073 | 5 | C | DYAZIDE | 1 | D | 0 | ||||||||||||
| 100160733 | 10016073 | 6 | C | CALCIUM | 1 | 1200 MG, DAILY | D | 0 | 1200 | MG |
Indications of drugs used
| Event ID | CASEID | INDI DRUG SEQ | INDI PT |
|---|---|---|---|
| 100160733 | 10016073 | 1 | Low density lipoprotein increased |
| 100160733 | 10016073 | 2 | Cardiovascular event prophylaxis |
| 100160733 | 10016073 | 3 | Hypercholesterolaemia |
| 100160733 | 10016073 | 4 | Blood pressure abnormal |
| 100160733 | 10016073 | 5 | Cardiac disorder |
| 100160733 | 10016073 | 6 | Vitamin supplementation |
Outcome of event
| Event ID | CASEID | OUTC COD |
|---|---|---|
| 100160733 | 10016073 | OT |
| 100160733 | 10016073 | HO |
Reactions reported
| Event ID | CASEID | DRUG REC ACT | PT |
|---|---|---|---|
| 100160733 | 10016073 | Renal failure | |
| 100160733 | 10016073 | Type 2 diabetes mellitus |
Reporting Sources (this data is often not reported and may therefore be missing here)
| no results found |
Therapies reported
| Event ID | CASEID | DSG DRUG SEQ | START DT | END DT | DUR | DUR COD |
|---|---|---|---|---|---|---|
| 100160733 | 10016073 | 1 | 200003 | 200706 | 0 | |
| 100160733 | 10016073 | 2 | 20100810 | 0 | ||
| 100160733 | 10016073 | 3 | 20100810 | 0 | ||
| 100160733 | 10016073 | 4 | 199901 | 0 | ||
| 100160733 | 10016073 | 6 | 200401 | 0 |